Kanazawa, Ippei http://orcid.org/0000-0001-9001-5609
Inaba, Masaaki
Inoue, Daisuke
Uenishi, Kazuhiro
Saito, Mitsuru
Shiraki, Masataka
Suzuki, Atsushi
Takeuchi, Yasuhiro
Hagino, Hiroshi
Fujiwara, Saeko
Sugimoto, Toshitsugu
,
Article History
Received: 2 June 2020
Accepted: 23 August 2020
First Online: 5 September 2020
Compliance with ethical standards
:
: IK has received research grants from MSD, Teijin pharma, and Novartis. MI has received research grants from Chugai Pharmaceutical, Kyowa-Kirin Co, Asahi Kasei Pharma, Ono Pharmaceutical, Novartis Pharma, Bayer Pharmaceutical, Roche DC Japan, Sumitomo Dainippon Pharma, Teijin Pharma, Takeda Pharmaceutical, and lecture and/or consulting fees from Chugai Pharmaceutical, Pfizer Inc, Bayer Pharmaceutical, Kyowa-Kirin Co, Kissei, Torii Pharmaceutical, Daiichi-Sankyo, and Ono Pharmaceutical. DI has received lecture and/or consulting fees from EA Pharma, Astellas Pharma, Asahi Kasei Pharma, Chugai Pharmaceutical, Daiichi-Sankyo Co., Ono Pharmaceutical and Teijin Pharma. MS has received research grants from Chugai Pharmaceutical Asahi Kasei Pharma and lecture fees from Chugai Pharmaceutical Astellas Amgen Biopharma Pfizer Inc Eli Lilly Daiichi-Sankyo Taisho Pharma Teijin Pharma and Asahi Kasei Pharma. MS has received consultant fee from Teijin pharma Co., Asahi Kasei Pharma Co, Daiichi-Sankyo. AS has received research grants from Kowa, Ono Pharmaceutical, Taisho Pharmaceutical, Chugai Pharmaceutical and Takeda Pharmaceutical, as well as lecture and/or consulting fees from Asahi Kasei Pharma, Astellas Pharma, Daiichi-Sankyo, Kyowa Kirin, Taisho Pharmaceutical, Chugai Pharmaceutical and Eli Lilly Japan. YT has received personal fees from Chugai, Daiichi-Sankyo, Teijin Pharma, Asahi Kasei Pharma and Kyowa Kirin. HH has received grants/research support or lecture fees from Asahi Kasei Pharma, Astellas Pharma, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly Japan, Mitsubishi Tanabe, Merck Sharp & Dohme, Mochida, Ono, Pfizer, Taisho Toyama Pharmaceutical, and Teijin Pharma. SF has received lecture fees from Teijin, Nippon-Zoki, and Astellas Amgen Japan. TS has received research grants from Astellas Pharma, Eisai, Daiichi-Sankyo, Chugai Pharmaceutical and Eli Lilly Japan, as well as lecture and/or consulting fees from Asahi Kasei Pharma and Daiichi-Sankyo.